RxDoctor Payments Data

Jack Wazen, MD

Otology & Neurotology · Sarasota, FLNPI 1801806757

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (44.1%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. Cochlear Americas accounts for 61.1% of it on its own, with 11 other manufacturers making up the rest. Reporting peaked in 2019 at $5,687 and has fallen 97.1% since, to $164 in 2025.

$16,336in general payments, 2019–2025

Across 71 payments — averaging $230.08 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Cochlear Americas$10K
  • Oticon Medical, LLC$2K
  • Med-el Corporation$1K
  • Advanced Bionics, LLC$948
  • Medical Device Business Services, Inc.$739
  • Acclarent, Inc$564
  • plus $454 from 6 others
$1,407in research payments, 2019–2025

Across 3 payments — averaging $468.87 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Advanced Bionics, LLC$1K

What the payments were for

  • Consulting fees$7,20044%
  • Travel & lodging$4,47227%
  • Food & beverage$4,66429%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$16,336 in reported general payments places this provider in the 80th percentile of 25 otology & neurotology providers in Florida.

See all otology & neurotology providers in Florida

Medicare billing

Part B allowed, 2024
$255,973
Medicare patients
804
Services billed
1,999

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Acetazolamide101$4,286
Ipratropium Bromide29$870
Meclizine Hcl18$291
Triamterene-HydrochlorothiazidTriamterene/Hydrochlorothiazid41$287
Topiramate17$168

Paid to pharmacies, not to this prescriber.

Other otology & neurotology in Sarasota

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →